Turn Therapeutics, Inc. (TTRX)
12.00
+0.61
(+5.36%)
USD |
NASDAQ |
Oct 09, 16:00
11.95
-0.05
(-0.42%)
After-Hours: 20:00
Turn Therapeutics Net Income (Quarterly) : -5.850M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.850M |
| March 31, 2026 | -0.971M |
| December 31, 2025 | 0.2791M |
| Date | Value |
|---|---|
| September 30, 2025 | -1.904M |
| June 30, 2025 | -1.240M |
| March 31, 2025 | -0.3285M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 5.534B |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 5.850M |
| EPS Diluted (Quarterly) | -0.1964 |
| Enterprise Value | 353.29M |
| Earnings Yield | -2.40% |
| Normalized Earnings Yield | -2.468 |